| EyeGate Pharma Receives Orphan Drug Designation For Corneal Graft Rejection From U.S. FDA (Medical News Today) |
|
|
EyeGate Pharma, the leader in ocular drug delivery, and a specialty pharmaceutical company using iontophoresis technology to safely and non-invasively deliver therapeutics to treat serious ocular diseases, announced that the U.S. |